Lobe Sciences Ltd. (CSE:LOBE)
Canada · Delayed Price · Currency is CAD 0.0850
+0.0050 (6.25%)
Aug 28, 2026, 9:04 AM EST
Lobe Sciences Market Cap
Lobe Sciences has a market cap or net worth of CAD 28.3 million as of August 28, 2026. Its market cap has increased by 169.14% in one year.
Market Cap
28.30M
Enterprise Value
24.74M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.09
ChartMarket Cap Chart
Since June 7, 2019, Lobe Sciences's market cap has increased from 17.41M to 28.30M, an increase of 62.50%. That is a compound annual growth rate of 6.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2026 | 28.30M | 133.33% |
| Dec 30, 2025 | 12.13M | 164.72% |
| Dec 31, 2024 | 4.58M | 131.55% |
| Dec 29, 2023 | 1.98M | -35.51% |
| Dec 30, 2022 | 3.07M | -54.48% |
| Dec 31, 2021 | 6.74M | -73.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 7, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Defence Therapeutics | 39.41M |
| Telescope Innovations | 39.20M |
| The More Life Company | 36.56M |
| Thiogenesis Therapeutics | 35.69M |
| Quantum BioPharma | 35.34M |
| Onco-Innovations | 34.16M |
| Resverlogix | 32.71M |
| Sharp Therapeutics | 27.37M |